About Technology Issues FAQ

Links

Official Page

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.